Literature DB >> 11914197

Is diabetic retinopathy an inflammatory disease?

A P Adamis.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11914197      PMCID： PMC1771111          DOI： 10.1136/bjo.86.4.363

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  35 in total

1.  Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.

Authors:  M Mizutani; T S Kern; M Lorenzi
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

2.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Authors:  L P Aiello; E A Pierce; E D Foley; H Takagi; H Chen; L Riddle; N Ferrara; G L King; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

3.  Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid.

Authors:  D S McLeod; D J Lefer; C Merges; G A Lutty
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

4.  Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels.

Authors:  T Murata; T Ishibashi; A Khalil; Y Hata; H Yoshikawa; H Inomata
Journal:  Ophthalmic Res       Date:  1995       Impact factor: 2.892

5.  Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.

Authors:  A P Adamis; D T Shima; M J Tolentino; E S Gragoudas; N Ferrara; J Folkman; P A D'Amore; J W Miller
Journal:  Arch Ophthalmol       Date:  1996-01

6.  Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy.

Authors:  F Malecaze; S Clamens; V Simorre-Pinatel; A Mathis; P Chollet; C Favard; F Bayard; J Plouet
Journal:  Arch Ophthalmol       Date:  1994-11

7.  Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis.

Authors:  D Shweiki; M Neeman; A Itin; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

8.  Decreased polymorphonuclear leukocyte deformability in NIDDM.

Authors:  Z Pécsvarády; T C Fisher; C H Darwin; A Fabók; T S Maqueda; M F Saad; H J Meiselman
Journal:  Diabetes Care       Date:  1994-01       Impact factor: 19.112

9.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

10.  Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

Authors:  J W Miller; A P Adamis; D T Shima; P A D'Amore; R S Moulton; M S O'Reilly; J Folkman; H F Dvorak; L F Brown; B Berse
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307
View more
  121 in total

1.  Apoptotic factors (Bcl-2 and Bax) and diabetic retinopathy in type 2 diabetes.

Authors:  Taoufik Khalfaoui; Nuria Basora; Amel Ouertani-Meddeb
Journal:  J Mol Histol       Date:  2010-06-08       Impact factor: 2.611

2.  The pathogenesis of diabetic retinopathy.

Authors:  M R Stanford
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

3.  Characterization of a mouse model of hyperglycemia and retinal neovascularization.

Authors:  Elizabeth P Rakoczy; Ireni S Ali Rahman; Nicolette Binz; Cai-Rui Li; Nermina N Vagaja; Marisa de Pinho; Chooi-May Lai
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

4.  Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2.

Authors:  Bojun Zhao; Gill Smith; Jun Cai; Aihua Ma; Mike Boulton
Journal:  Br J Ophthalmol       Date:  2006-08-30       Impact factor: 4.638

5.  Safety, tolerability, and bioavailability of topical SAR 1118, a novel antagonist of lymphocyte function-associated antigen-1: a phase 1b study.

Authors:  D M Paskowitz; Q D Nguyen; P Gehlbach; J T Handa; S Solomon; W Stark; O Shaikh; C Semba; T R Gadek; D V Do
Journal:  Eye (Lond)       Date:  2012-04-27       Impact factor: 3.775

6.  Correlation of morphological pattern of optical coherence tomography in diabetic macular edema with systemic risk factors in middle aged males.

Authors:  Sambuddha Ghosh; Preeti Bansal; Harsha Shejao; Raghuraj Hegde; Debesh Roy; Shyamapada Biswas
Journal:  Int Ophthalmol       Date:  2014-03-01       Impact factor: 2.031

7.  NAD(P)H oxidase-dependent regulation of CCL2 production during retinal inflammation.

Authors:  Wenbo Zhang; Modesto Rojas; Brenda Lilly; Nai-Tse Tsai; Tahira Lemtalsi; Gregory I Liou; Robert W Caldwell; Ruth B Caldwell
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

8.  Chronic systemic hypoxia causes intra-retinal angiogenesis.

Authors:  Alex J Shortt; Katherine Howell; Colm O'Brien; Paul McLoughlin
Journal:  J Anat       Date:  2004-11       Impact factor: 2.610

Review 9.  Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy.

Authors:  David J Ramsey; G B Arden
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

10.  Neural inflammation and the microglial response in diabetic retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Ocul Biol Dis Infor       Date:  2012-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.